ArticleScientific reports2025
NMR- and MS-based multiplex approach for comparative metabolome profiling of Curcuma caesia versus curcuma longa rhizomes and in relation to in vitro biological effects.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The study presents the first integrated comparative metabolomics approach of Curcuma caesia known as blue curcuma, that is relatively less explored, compared with the well-known yellow curcuma Curcuma longa using a multiplex analytical approach viz., UV, NMR, UPLC/MS/MS, GC/MS and SPME/GC/MS. The study targeted fingerprinting and chemical characterization of their primary and secondary metabolites as well as annotation of volatiles affecting their aroma and culinary uses. Datasets were further modelled using multivariate data analyses (PCA and OPLS) for samples' classification and discrimination. The study revealed several newly reported metabolites in blue curcuma and assigned discriminating biomarkers for each species i.e. sesquiterpenes in blue curcuma vs. curcuminoids in yellow curcuma. Bioactivity assays, including antioxidant and antidiabetic activities, showed moderate activity for C. caesia relative to C. longa, while both species were inactive as anti-obesity agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.